Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A fibrosarcoma that occurs in infants. It shares identical morphologic features with adult fibrosarcoma but carries the t(12;15)(p13;q25) translocation that results in ETV6-NTRK3 gene fusion. It usually affects the superficial and deep soft tissues of the extremities. The prognosis is generally much more favorable than for adult fibrosarcoma, and it rarely metastasizes.
Biomarker and diagnostic research for congenital fibrosarcoma has been reported in the published literature.
2 clinical trials registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE2, 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
58 publications have been identified in PubMed for congenital fibrosarcoma. Research spans Case Report / Case Series (48%), Review / Meta-Analysis (16%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 28 | 48% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:30 AM UTC
Research summaries |
9 |
16% |
Laboratory research | 7 | 12% |
Other research | 4 | 7% |
Disease patterns and progression | 4 | 7% |
New treatment approaches | 3 | 5% |
Testing and diagnosis research | 2 | 3% |
Clinical study results | 1 | 2% |
Yeung MCF (2026). [PMID: 42192570](https://pubmed.ncbi.nlm.nih.gov/42192570/). *Genes Chromosomes Cancer*. [Basic Science / Preclinical]
Escobar Howard M (2026). [PMID: 42046583](https://pubmed.ncbi.nlm.nih.gov/42046583/). *Cureus*. [Case Report / Case Series]
McKay KG (2026). [PMID: 41509607](https://pubmed.ncbi.nlm.nih.gov/41509607/). *EClinicalMedicine*. [Epidemiology / Natural History]
Kenji N (2026). [PMID: 41589225](https://pubmed.ncbi.nlm.nih.gov/41589225/). *Int Cancer Conf J*. [Gene Therapy / Novel Therapeutics]
Vaile JR (2026). [PMID: 41439260](https://pubmed.ncbi.nlm.nih.gov/41439260/). *J Hand Surg Glob Online*. [Case Report / Case Series]
Zhu F (2026). [PMID: 41349474](https://pubmed.ncbi.nlm.nih.gov/41349474/). *Oncologist*. [Epidemiology / Natural History]
Zhang J (2026). [PMID: 41400459](https://pubmed.ncbi.nlm.nih.gov/41400459/). *Clin Nucl Med*. [Case Report / Case Series]
Ibáñez-Navarro A (2026). [PMID: 41982953](https://pubmed.ncbi.nlm.nih.gov/41982953/). *Transl Pediatr*. [Other]
Flucke U (2026). [PMID: 41603898](https://pubmed.ncbi.nlm.nih.gov/41603898/). *Pathologie (Heidelb)*. [Review / Meta-Analysis]
Rathod G (2026). [PMID: 42003167](https://pubmed.ncbi.nlm.nih.gov/42003167/). *Curr Pediatr Rev*. [Diagnostic / Biomarker]